These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current treatment of age-related macular degeneration. Zarbin M; Szirth B Optom Vis Sci; 2007 Jul; 84(7):559-72. PubMed ID: 17632299 [TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of treatment of age-related macular degeneration: a review. Kymes Steven M Minerva Med; 2009 Feb; 100(1):69-78. PubMed ID: 19277005 [TBL] [Abstract][Full Text] [Related]
12. [Guidance for the treatment of neovascular age-related macular degeneration (AMD)]. Karska-Basta I; Kubicka-Trzaska A; Oleksy P; Romanowska-Dixon B Przegl Lek; 2009; 66(11):972-5. PubMed ID: 20297641 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of vitreous hemorrhage secondary to exudative age-related macular degeneration. Hasegawa T; Otani A; Sasahara M; Gotoh N; Ooto S; Tamura H; Yamashiro K; Tsujikawa A; Yoshimura N Am J Ophthalmol; 2010 Feb; 149(2):322-329.e1. PubMed ID: 20103057 [TBL] [Abstract][Full Text] [Related]
14. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Richer S; Devenport J; Lang JC Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338 [TBL] [Abstract][Full Text] [Related]
15. The potential effect of population development, smoking and antioxidant supplementation on the future epidemiology of age-related macular degeneration in Switzerland. Bauer P; Barthelmes D; Kurz M; Fleischhauer JC; Sutter FK Klin Monbl Augenheilkd; 2008 May; 225(5):376-9. PubMed ID: 18454376 [TBL] [Abstract][Full Text] [Related]
16. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737 [TBL] [Abstract][Full Text] [Related]
17. [Intravitreal anti-VEGF injections improve the visual prognosis of wet age related macular degeneration]. Ambresin A; Mantel I Rev Med Suisse; 2007 Jan; 3(94):137-41. PubMed ID: 17354539 [TBL] [Abstract][Full Text] [Related]
18. Carotenoids and co-antioxidants in age-related maculopathy: design and methods. Neelam K; Hogg RE; Stevenson MR; Johnston E; Anderson R; Beatty S; Chakravarthy U Ophthalmic Epidemiol; 2008; 15(6):389-401. PubMed ID: 19065432 [TBL] [Abstract][Full Text] [Related]
19. Emerging therapies for neovascular age-related macular degeneration: state of the art. Donati G Ophthalmologica; 2007; 221(6):366-77. PubMed ID: 17947822 [TBL] [Abstract][Full Text] [Related]
20. Age-related macular degeneration: a leading cause of blindness. O'Shea JG Med J Aust; 1996 Nov; 165(10):561-4. PubMed ID: 8941243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]